These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29204)

  • 1. Destruction of post-synaptic dopamine receptors prevents neuroleptic-induced activation of striatal tyrosine hydroxylase but not dopamine synthesis stimulation.
    Di Chiara G; Onali PL; Tissari AH; Porceddu ML; Morelli M; Gessa GL
    Life Sci; 1978 Aug; 23(7):691-6. PubMed ID: 29204
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine-synthesis and tyrosine-hydroxylase are regulated by independent DA-receptor mediated mechanisms.
    Tissari HA; Porceddu ML; Argiolas A; Di Chiara G; Gessa GL
    Life Sci; 1978 Aug; 23(6):653-8. PubMed ID: 29202
    [No Abstract]   [Full Text] [Related]  

  • 3. Increase of dopamine synthesis in synaptosomes from rats treated with neuroleptics or reserpine.
    Tissari AH
    Med Biol; 1982 Feb; 60(1):38-41. PubMed ID: 6121960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The regulation of the kinetic state of striatal tyrosine hydroxylase and the role of postsynaptic dopamine receptors.
    Zivkovic B; Guidotti A; Costa E
    Brain Res; 1975 Jul; 92(3):516-21. PubMed ID: 240486
    [No Abstract]   [Full Text] [Related]  

  • 5. Regulatory mechanisms of dopamine biosynthesis at the tyrosine hydroxylase step.
    Goldstein M
    Ann N Y Acad Sci; 1984; 430():1-5. PubMed ID: 6146282
    [No Abstract]   [Full Text] [Related]  

  • 6. Nonstriatal dopaminergic neurons: role of presynaptic receptors in the modulation of transmitter synthesis.
    Roth RH; Nowycky MC
    Adv Biochem Psychopharmacol; 1977; 16():465-70. PubMed ID: 18895
    [No Abstract]   [Full Text] [Related]  

  • 7. Nigrostriatal dopamine neurons: modulation of impulse-induced activation of tyrosine hydroxylation by dopamine autoreceptors.
    Murrin LC; Roth RH
    Neuropharmacology; 1987 Jun; 26(6):591-5. PubMed ID: 2885775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of the dopamine agonist pergolide on tyrosine hydroxylase activity in rat striatal and limbic miniprisms in vitro: a model for the dopamine autoreceptor?
    Vulto AG; Fowler CJ
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug; 333(4):349-53. PubMed ID: 2877399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in receptors controlling dopamine synthesis after chronic ethanol ingestion.
    Tabakoff B; Hoffman PL
    J Neurochem; 1978 Nov; 31(5):1223-9. PubMed ID: 29948
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of haloperidol on dopamine synthesis and tyrosine hydroxylase in striatal synaptosomes.
    Kapatos G; Zigmond MJ
    J Pharmacol Exp Ther; 1979 Mar; 208(3):468-75. PubMed ID: 34711
    [No Abstract]   [Full Text] [Related]  

  • 11. Dopaminergic agonist and antagonist effects on striatal tyrosine hydroxylase distribution.
    Smith CP; Ellis DB; Meyerson LR
    Life Sci; 1981 Jan; 28(2):193-7. PubMed ID: 6114374
    [No Abstract]   [Full Text] [Related]  

  • 12. Tolerance to tyrosine hydroxylase activation in n. accumbens and c. striatum after repeated injections of "classical" and "atypical" antischizophrenic drugs.
    Guidotti A; Gale K; Toffano G; Vargas FM
    Life Sci; 1978 Aug; 23(5):501-5. PubMed ID: 29190
    [No Abstract]   [Full Text] [Related]  

  • 13. Dopamine autoreceptor regulation of the kinetic state of striatal tyrosine hydroxylase.
    Strait KA; Kuczenski R
    Mol Pharmacol; 1986 Jun; 29(6):561-9. PubMed ID: 2872588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of kinetic constant of striatal tyrosine hydroxylase elicited by neuroleptics that impair the function of dopamine receptors.
    Zivkovic B; Guidotti A
    Brain Res; 1974 Oct; 79(3):505-9. PubMed ID: 4153770
    [No Abstract]   [Full Text] [Related]  

  • 15. Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors.
    Sanberg PR
    Nature; 1980 Apr; 284(5755):472-3. PubMed ID: 7189016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors.
    Claustre Y; Fage D; Zivkovic B; Scatton B
    J Pharmacol Exp Ther; 1985 Feb; 232(2):519-25. PubMed ID: 2857197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SCH 23390, a selective D1 dopamine receptor blocker, enhances the firing rate of nigral dopaminergic neurons but fails to activate striatal tyrosine hydroxylase.
    Onali P; Mereu G; Olianas MC; Bunse B; Rossetti Z; Gessa GL
    Brain Res; 1985 Aug; 340(1):1-7. PubMed ID: 2862956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of dopamine synthesis on methamphetamine-induced changes in striatal and adrenal tyrosine hydroxylase activity.
    Gibb JW; Kogan FJ
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Dec; 310(2):185-7. PubMed ID: 43481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranigral application of substance P antagonists prevents the haloperidol-induced activation of striatal tyrosine hydroxylase.
    Melis MR; Gale K
    Naunyn Schmiedebergs Arch Pharmacol; 1984 May; 326(1):83-6. PubMed ID: 6206401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Participation of GABA receptors in the short-term activation of striatal tyrosine-3-monooxygenase elicited by neuroleptics.
    Guidotti A; Gale K
    Adv Biochem Psychopharmacol; 1977; 16():455-60. PubMed ID: 18893
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.